<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000560639">
  <TermName>yttrium Y 90-DOTA monoclonal antibody HuAFP31</TermName>
  <TermPronunciation>(IH-tree-um … MAH-noh-KLOH-nul AN-tee-BAH-dee …)</TermPronunciation>
  <TermDefinition>
    <DefinitionText>A substance being studied in the treatment of liver cancer. HuAFP31 is a monoclonal antibody that binds to a protein called alpha fetoprotein (AFP), which is found on some cancer cells. It is linked to a radioactive substance called yttrium Y 90, which may help kill cancer cells. Yttrium Y 90-DOTA monoclonal antibody HuAFP31 is a type of radioimmunoconjugate.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <MediaLink ref="CDR0000721068" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;yttrium Y 90 DOTA monoclonal antibody HuAFP31&quot;" language="en" id="_3"/>
  <MediaLink ref="CDR0000721067" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;itrio Y 90-DOTA-anticuerpo monoclonal HuAFP31&quot;" language="es" id="_4"/>
  <SpanishTermName>itrio Y 90-DOTA-anticuerpo monoclonal HuAFP31</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Sustancia en estudio para el tratamiento del cáncer de hígado. El HuAFP31 es un anticuerpo monoclonal que se une a una proteína: la alfaproteína (AFP), que se encuentra en algunas células cancerosas. Se la enlaza a una sustancia radiactiva, el itrio Y 90, que tal vez ayude a destruir las células cancerosas. El itrio Y 90-DOTA-anticuerpo monoclonal HuAFP31 es un tipo de radioinmunoconjugado.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateFirstPublished>2008-03-10</DateFirstPublished>
  <DateLastModified>2017-10-24</DateLastModified>
</GlossaryTerm>
